Riyadh, Saudi Arabia – 25 November,
2025: Algorithm, a pioneering regional pharmaceutical manufacturer has announced
the signing of a strategic partnership agreement with Batterjee Pharma, a
leading Saudi pharmaceutical company, becoming the first Lebanese company to localize
its portfolio in the Kingdom.
The
agreement covers the manufacturing and supply of several EU & Japanese
licensed Algorithm products.
The
collaboration will kick off with products targeting the treatment of critical
therapeutic areas as hyperlipidemia, dyslipidemia & hypertension with full
technology transfer by mid-2026.
Aligned
with KSA’s Health Sector Transformation Program under Vision 2030, this
partnership will strengthen the Kingdom’s healthcare infrastructure, reduce
reliance on imports, and enhance treatment standards.
Statements:
Dr. Mohamed Mazen Batterjee, CEO of Batterjee
Pharma
“This
collaboration is about impact: ensuring the uninterrupted supply of essential
medicines for patients, creating valuable job opportunities, and driving higher
local content in line with national priorities. Together with Algorithm, we are
not only enhancing healthcare access today but also laying the foundation for a
resilient and sustainable pharmaceutical sector in the region.
At
Batterjee Pharma, we take pride in being a dynamic, trusted, and responsive
organization — one that builds meaningful partnerships and delivers value
through innovation and reliability. This agreement with Algorithm marks only
the beginning of a series of collaborative projects between our two companies,
underscoring our long-term commitment to shaping the future of healthcare in
Saudi Arabia and beyond.”
Nabil Ghorayeb, Human Health and Manufacturing
Director, Algorithm
“KSA
Localization Project is a bold milestone in Algorithm’s journey – a testimony
to our pioneering leadership. In partnership with Batterjee Pharma, we are
localizing the manufacturing of highly differentiated therapies that address
significant unmet medical needs – expediting access to innovation where it’s
needed most.
This
project not only supports Saudi Arabia’s Vision 2030 but also fuels sustainable
economic growth through knowledge transfer, and healthcare resilience. It is
more than a localization strategy - a regional blueprint for how purpose-driven
innovation can deliver impact at scale and redefine the future of healthcare
across the MENA”.
About
Algorithm
Algorithm is a Lebanese regional pharmaceutical company committed to improving
human health and well-being across the MENA. For
more information
About
Batterjee Pharma
Batterjee Pharma is a Saudi pharmaceutical company offering a range of
medicines and CDMO services. For more information
*Source: AETOSWire
Contacts:
Algorithm Media Inquiries
Marwa Tabsh
mstabsh@algorithm-lb.com
|